View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Bortezomib 1.3 / Cyclophosphamide 900 / Dexamethasone 40, Multiple Myeloma
Protocol-ID: 532 V1.1 (Mini), BORT1.3/CYCL900/DEXA40, MMIndication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- GMMG MM5 Trial In Newly Diagnosed Multiple Myeloma To Evaluate PAd Vs VCD Induction Prior To High Dose Treatment Followed By Lenalidomide Consolidation and Maintenance – Final Analysis On Induction Therapy [Medical Journal]
- Velcade, Intravenous Cyclophosphamide and Dexamethasone (VCD) Induction for Previously Untreated Multiple Myeloma (German DSMM XIa Trial). [Medical Journal]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.05.2021